Introduction
Human CD274/PD-L1/B7-H1 HEK293T Stable Cell Line is a valuable tool for studying the role of the programmed death-ligand 1 (PD-L1) protein in cancer and immune system regulation. This stable cell line expresses high levels of PD-L1, allowing for reliable and consistent analysis of its structure, activity, and potential therapeutic applications. In this article, we will discuss the key features and applications of this cell line, with a focus on its use in flow cytometry and as a therapeutic target.
Structure of Human CD274/PD-L1/B7-H1 HEK293T Stable Cell Line
The Human CD274/PD-L1/B7-H1 HEK293T Stable Cell Line is derived from the human embryonic kidney 293T cell line, a commonly used cell line in biomedical research. This stable cell line has been genetically modified to express high levels of the PD-L1 protein, which is encoded by the CD274 gene. PD-L1 is a type I transmembrane protein that belongs to the B7 family of immune checkpoint molecules. It consists of a single extracellular domain, a transmembrane domain, and a cytoplasmic domain. The extracellular domain of PD-L1 contains a highly conserved IgV-like domain, which is responsible for its interaction with the programmed death-1 (PD-1) receptor on T cells.
Activity of Human CD274/PD-L1/B7-H1 HEK293T Stable Cell Line
The primary function of PD-L1 is to inhibit the immune response by binding to the PD-1 receptor on T cells, leading to T cell exhaustion and suppression of immune activity. This mechanism is exploited by cancer cells to evade immune surveillance and promote tumor growth. The Human CD274/PD-L1/B7-H1 HEK293T Stable Cell Line mimics this activity by overexpressing PD-L1, making it a valuable tool for studying the role of PD-L1 in cancer and immune system regulation.
Flow Cytometry Analysis
Flow cytometry is a powerful technique that allows for the analysis of individual cells based on their physical and biochemical characteristics. The high expression of PD-L1 in the Human CD274/PD-L1/B7-H1 HEK293T Stable Cell Line makes it an ideal tool for flow cytometry analysis. By labeling the cell line with fluorescently labeled antibodies specific for PD-L1, researchers can easily quantify the expression levels of PD-L1 on the cell surface. This information can then be used to study the regulation of PD-L1 expression and its interaction with the PD-1 receptor.
Therapeutic Target
The overexpression of PD-L1 in many types of cancer has made it a promising therapeutic target. By blocking the interaction between PD-L1 and the PD-1 receptor, immune activity can be restored, leading to enhanced anti-tumor immune responses. The Human CD274/PD-L1/B7-H1 HEK293T Stable Cell Line can be used to screen for potential inhibitors of the PD-L1/PD-1 pathway, allowing for the development of novel cancer immunotherapies.
Applications in Cancer Research
The Human CD274/PD-L1/B7-H1 HEK293T Stable Cell Line has been used in various cancer research studies, including investigating the role of PD-L1 in tumor growth and metastasis, as well as testing the efficacy of PD-L1 inhibitors as potential cancer treatments. Additionally, this cell line has been used to study the effects of different cancer therapies on PD-L1 expression, providing valuable insights into the mechanisms of action of these treatments.
Other Applications
Apart from its use in cancer research, the Human CD274/PD-L1/B7-H1 HEK293T Stable Cell Line has also been used in other areas of study, such as autoimmune diseases and infectious diseases.
There are no reviews yet.